Faron Pharmaceuticals Oy (DI) (FARN) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Sep 2016 03:59 PM
RNS
Director Dealing
21 Sep 2016 11:27 AM
RNS
Raises £8.0 M through a Placing and Subscription
20 Sep 2016 07:00 AM
RNS
Proposed Placing & Subscription to raise £8M
05 Sep 2016 07:00 AM
RNS
Interim Results for six months ended 30 June 2016
10 Aug 2016 07:00 AM
RNS
Faron Pharmaceuticals Notice of Interim Results
25 Jul 2016 07:00 AM
RNS
Faron enters agreement with Abzena for Clevegen
22 Jun 2016 12:00 PM
RNS
Faron to Present at Proactive Investors Forum
14 Jun 2016 07:00 AM
RNS
Faron Provides Update at R&D Day
13 Jun 2016 07:00 AM
RNS
Faron Licenses Traumakine Rights to Pharmbio Korea
26 May 2016 10:53 AM
RNS
Faron Result of Annual General Meeting
26 May 2016 07:00 AM
RNS
Faron Expands R&D Strategy for Clevegen
13 May 2016 07:00 AM
RNS
Faron Pharmaceuticals Ltd to host an R&D Day
04 May 2016 07:00 AM
RNS
Notice of AGM
03 May 2016 07:00 AM
RNS
Faron Appoints New Medical Director
22 Apr 2016 07:00 AM
RNS
Faron Appoints Panmure Gordon as Joint Broker
19 Apr 2016 07:00 AM
RNS
Faron Files Two New Patents to Protect Clevegen
10 Mar 2016 07:00 AM
RNS
Annual Results for the year ended 31 December 2015
01 Mar 2016 07:00 AM
RNS
Faron files patent application for Traumakine
10 Feb 2016 07:00 AM
RNS
Notice of Preliminary Results
07 Jan 2016 07:00 AM
RNS
Top-line results from Japanese study of Traumakine
29 Dec 2015 07:00 AM
RNS
First Patient recruited in Phase III ARDS Study
21 Dec 2015 07:00 AM
RNS
Faron Awarded ?1.5 million Tekes Funding
30 Nov 2015 07:00 AM
RNS
Key Publication in Journal of Immunology
17 Nov 2015 07:30 AM
RNS
Admission to AIM and first day of dealings
UK 100

Latest directors dealings